In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 
Poster session 3: Ventricular Arrhythmias and SCD - Epidemiology, Prognosis, Outcome
Session

Congress : EHRA 2019

Topic : Other

  • Session type : Poster Session
  • Date : 19 March 2019
  • Time : 08:30 - 12:30

18 presentations in this session

Association between ventricular fibrillation recurrences and chest compressions in out-of-hospital cardiac arrest

Congress : EHRA 2019

  • Session : Ventricular Arrhythmias and SCD - Epidemiology, Prognosis, Outcome
  • Speaker : F Guerra (Ancona,IT)

Clinical impact on ventricular arrhythmic risk of serum free thyroxine concentration in euthyroid patients with structural heart diseases

Congress : EHRA 2019

  • Session : Ventricular Arrhythmias and SCD - Epidemiology, Prognosis, Outcome
  • Speaker : H Makimoto (Duesseldorf,DE)

Precedent non-sustained ventricular tachycardias predicts subsequent ICD interventions and heart failure hospitalization in primary prevention ICD patients

Congress : EHRA 2019

  • Session : Ventricular Arrhythmias and SCD - Epidemiology, Prognosis, Outcome
  • Speaker : H Makimoto (Duesseldorf,DE)

P-wave morphology and risk of sudden cardiac death in patients with coronary artery disease

Congress : EHRA 2019

  • Session : Ventricular Arrhythmias and SCD - Epidemiology, Prognosis, Outcome
  • Speaker : J Perkiomaki (Oulu,FI)

10-year trends in the use of catheter ablation for the treatment ofVT versus other ablation procedures and PCI for the treatment of IHD

Congress : EHRA 2019

  • Session : Ventricular Arrhythmias and SCD - Epidemiology, Prognosis, Outcome
  • Speaker : R Anderson (Melbourne,AU)

Predictive role of invasive electrophysiological study in patients with active vs. previous myocarditis

Congress : EHRA 2019

  • Session : Ventricular Arrhythmias and SCD - Epidemiology, Prognosis, Outcome
  • Speaker : G Peretto (Milan,IT)

Risk factors for ventricular arrhythmias in cardiac-variant fabry disease

Congress : EHRA 2019

  • Session : Ventricular Arrhythmias and SCD - Epidemiology, Prognosis, Outcome
  • Speaker : F Varian (Sheffield,GB)

Does the level advancement of coronary artery disease predicts the appearance of ventricular arrhythmia?

Congress : EHRA 2019

  • Session : Ventricular Arrhythmias and SCD - Epidemiology, Prognosis, Outcome
  • Speaker : E Gadula-Gacek (Zabrze,PL)

Case control analysis shows high burden of CASQ2 variants in a large cohort of sudden arrhythmic death syndrome victims

Congress : EHRA 2019

  • Session : Ventricular Arrhythmias and SCD - Epidemiology, Prognosis, Outcome
  • Speaker : B Gray (London,GB)

Early repolarization pattern in children: differences between Caucasian and North-Malagasy population

Congress : EHRA 2019

  • Session : Ventricular Arrhythmias and SCD - Epidemiology, Prognosis, Outcome
  • Speaker : A Creta (London,GB)

Impact of cardiac tachyarrhtythmias recorded in Coronary Intensive Care Unit (CICU) on short and long-term mortality and duration of CICU hospitalization

Congress : EHRA 2019

  • Session : Ventricular Arrhythmias and SCD - Epidemiology, Prognosis, Outcome
  • Speaker : P Papakonstantinou (Athens,GR)

Periodic repolarization dynamics and risk of sudden cardiac death in patients with stable coronary artery disease

Congress : EHRA 2019

  • Session : Ventricular Arrhythmias and SCD - Epidemiology, Prognosis, Outcome
  • Speaker : A Kiviniemi (Oulu,FI)

Characterisation of sudden death circumstances in young adults. Insights from a 6-year web-based Italian study.

Congress : EHRA 2019

  • Session : Ventricular Arrhythmias and SCD - Epidemiology, Prognosis, Outcome
  • Speaker : A Baccelli (Lucca,IT)

no speaker photo speaker

Frances Varian

Sheffield Teaching Hospitals NHS Trust, Sheffield (United Kingdom of Great Britain & Northern Ireland)
1
no speaker photo speaker

Elzbieta Gadula-Gacek

Silesian Center for Heart Diseases (SCHD), Zabrze (Poland)
4
no speaker photo speaker

Belinda Gray

Royal Prince Alfred Hospital, Sydney (Australia)
4
no speaker photo speaker

Associate Professor Hisaki Makimoto

Heinrich Heine University, Duesseldorf (Germany)
6
Pasquale Vergara speaker

Pasquale Vergara

San Raffaele Hospital, Milan (Italy)
2
no speaker photo speaker

Miry Blich

Rambam Health Care Campus, Haifa (Israel)
2
Giovanni Peretto speaker

Giovanni Peretto

San Raffaele Hospital, Milan (Italy)
27
no speaker photo speaker

Robert Anderson

Royal Melbourne Hospital, Melbourne (Australia)
2
Assistant Professor Federico Guerra speaker

Assistant Professor Federico Guerra

Marche Polytechnic University of Ancona, Ancona (Italy)
20
no speaker photo speaker

Antti Kiviniemi

University of Oulu, Oulu (Finland)
5
Panteleimon Papakonstantinou speaker

Panteleimon Papakonstantinou

Hippokration General Hospital, Athens (Greece)
7
Andrea Baccelli speaker

Andrea Baccelli

Policlinic Foundation San Matteo IRCCS, Pavia (Italy)
1
no speaker photo speaker

Carmen Adduci

Sapienza University of Rome, Rome (Italy)
3
Paola Marta Berne speaker

Paola Marta Berne

San Francesco Hospital, Nuoro (Italy)
1
no speaker photo speaker

Antonio Creta

Barts Heart Centre, London (United Kingdom of Great Britain & Northern Ireland)
2
no speaker photo speaker

Juha Perkiomaki

Oulu University Hospital, Oulu (Finland)
2
Anne-Lotte van der Lingen speaker

Anne-Lotte van der Lingen

Amsterdam UMC - Location VUmc, Amsterdam (Netherlands (The))
4

Members get more

Join now
  • 1ESC Professional Members – access all resources from ESC Congress and ESC Asia with APSC & AFC
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s congress resources
  • 3Under 40 or in training - with a Combined Membership, access resources from all congresses
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are